Home » Medtronic Investors Sue Over $3 Billion Inflated Stock Buyback
Medtronic Investors Sue Over $3 Billion Inflated Stock Buyback
Medtronic investors accused the medical device maker’s directors of making misleading statements about their marketing of the company’s bone growth-stimulating device for off-label uses, causing the company to repurchase more than $2.8 billion of its own stock at inflated prices.
Law360
Law360
Upcoming Events
-
07May
-
14May
-
30May